There is so much to be said about the ovaries in relation to fertility and many young women showed genuine interest in learning about their own biology, while having thoughtful discussions with Stine Gry Kristensen and Sandra Søgaard Tøttenborg.

Between April and June, nine ReproUnion-affiliated young researchers and doctors participated the 12-week online e-Campus Innovation Course, a programme developed in collaboration with SmiLe Venture...

The European Mental Health Week was a timely opportunity to shed light on the emotional strain that fertility treatments place on individuals and couples. By addressing both medical and emotional needs, a ReproUnion Innovation project aspires to support fertility treatment to make it more effective, less isolating, and more humane.

As one of the first commercial partners to access the ReproUnion Biobank & Infertility Cohort (RUBIC), Caerus Biotech is collaborating with Rigshospitalet to analyze samples from 1000 men, using the company’s MiOXSYS system designed to measure oxidative stress in semen.

At the event organized by ReproYoung the topic was male and female infertility – assessment and prognostic factors with talks by Anja Pinborg and Niels Jørgensen from Rigshospitalet.

This third episode of the Business Review Life Science podcast series brings together diverse perspectives from academia, industry, and healthcare and dives into the urgent topic of involuntary childlessness and explores how public-private collaboration is key to finding innovative fertility solutions.

Human Reproduction has published the findings from the largest existing study, to examine the link between semen quality and mortality, based on data from nearly 80,000 men. The main authors are also part of ReproUnion.

Dx4Life is the first start-up to emerge from the ReproUnion Innovation Platform, and the collaboration with RMC is a strong example of the translational research that ReproUnion fosters to bridge the gap between laboratory discoveries and clinical application.

At the workshop, co-organized with LU Innovation and Reproduktionmedicinskt Centrum (RMC), the clinicians explored an innovation framework which underlines the distinction that an invention isn’t truly an innovation until it’s successfully implemented.

ReproUnion hosted ReproYoung 2.0 for their re-launch and first ReproTalk event to explore parenthood – Is it important to have children? and what happens when biology becomes an enemy?